Approval · Notice of Compliance 22718 · 2019
ACCEL-TROSPIUM: Notice of Compliance 22718
Issued September 30, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22718
- Date
- September 30, 2019
- Company
- Accel Pharma IncPointe Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- TROSEC (Sunovion Pharmaceuticals Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACCEL-TROSPIUM | 02492717 | Cancelled Pre Market |
Medicinal ingredients
- TROSPIUM CHLORIDE 20 MG per TAB